Clinical trial
Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal…
NCT00335452 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00335452 |
|---|---|
| Title | Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS |
| Official title | Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy. |
| Acronym | CURRENT/OASIS7 |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Coronary Disease, Angina Unstable |
| Intervention type | Drug |
| Interventions | Clopidogrel, acetylsalicyclic acid (ASA) |
| Enrollment | 25,086 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jun 9, 2006 |
| Last update posted | Nov 18, 2010 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, Estonia and 26 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: